- RecruitingPHASE3
An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
This study is testing different treatments for Alzheimer's disease in people aged 55 and over. It aims to see if new medications can help improve memory, thinking, and daily activities over 18 months, compared to a dummy pill.
For: Alzheimer's Disease (AD) · Mild Cognitive Impairment Due to Alzheimer's Disease · Alzheimer Disease DementiaUnited Kingdom - CompletedPhase II
Noradrenaline treatment of apathy and impulsivity in participants with Progressive Supranuclear Palsy syndromes
This UK clinical trial is testing a medicine called atomoxetine for people with Progressive Supranuclear Palsy (PSP). Researchers want to see if boosting a natural brain chemical can safely improve motivation, attention, and impulsive behaviours. All participants receive both the medicine and a dummy pill at different times.
For: Progressive supranuclear palsyUnited Kingdom · England · Scotland - Not yet recruitingPHASE4
Study of the Effects of Atomoxetine on Motivation
This study looks at how a medicine called atomoxetine affects motivation in people with apathy, which is when you feel very low on drive and energy. We want to see if increasing a brain chemical called noradrenaline can help people feel more motivated and focus better.
For: ApathyUnited Kingdom - CompletedNot Applicable
Understanding how increasing some of the brain's chemicals can help thinking and behaviour in people with Parkinson’s disease
Researchers in Cambridge are studying whether a medicine called atomoxetine can improve thinking, attention, and decision-making in people with Parkinson’s disease. The medicine works by temporarily raising a brain chemical called noradrenaline. Volunteers attend two hospital visits to compare a single dose of the medicine against a dummy pill.
For: Parkinson's diseaseUnited Kingdom · England - RecruitingNA
Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)
This study looks at how a low dose of a specific drug, atomoxetine, affects how healthy people learn. It compares the drug to a dummy pill to understand how a brain chemical called noradrenaline influences learning and decision-making.
For: Role of the Noradrenergic System in the Regulation of Learning Dynamics · No Disease or Condition is Being StudiedFrance